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Abstract  
Background 
Precise prediction of cancer types is vital for cancer diagnosis and therapy. Important 
cancer marker genes can be inferred through predictive model. Several studies have 
attempted to build machine learning models for this task however none has taken into 
consideration the effects of tissue of origin that can potentially bias the identification of 
cancer markers. 
Results 
In this paper, we introduced several Convolutional Neural Network (CNN) models that 
take unstructured gene expression inputs to classify tumor and non-tumor samples into 
their designated cancer types or as normal. Based on different designs of gene embeddings 
and convolution schemes, we implemented three CNN models: 1D-CNN, 2D-Vanilla-
CNN, and 2D-Hybrid-CNN. The models were trained and tested on combined 10,340 
samples of 33 cancer types and 731 matched normal tissues of The Cancer Genome Atlas 
(TCGA). Our models achieved excellent prediction accuracies (93.9-95.0%) among 34 
classes (33 cancers and normal). Furthermore, we interpreted one of the models, known as 
1D-CNN model, with a guided saliency technique and identified a total of 2,090 cancer 
markers (108 per class). The concordance of differential expression of these markers 
between the cancer type they represent and others is confirmed. In breast cancer, for 
instance, our model identified well-known markers, such as GATA3 and ESR1. Finally, we 
extended the 1D-CNN model for prediction of breast cancer subtypes and achieved an 
average accuracy of 88.42% among 5 subtypes. The codes can be found at  
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https://github.com/chenlabgccri/CancerTypePrediction.  
Conclusions 
Here we present novel CNN designs for accurate and simultaneous cancer/normal and 
cancer types prediction based on gene expression profiles, and unique model interpretation 
scheme to elucidate biologically relevance of cancer marker genes after eliminating the 
effects of tissue-of-origin. The proposed model had light hyperparameters to be trained and 
thus can be easily adapt to facilitate cancer diagnosis in the future. 
Keywords: Deep Learning; Convolutional Neural Networks, The Cancer Genome Atlas; 
Cancer type prediction; Cancer gene markers; Breast cancer subtype prediction   
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Background  
Cancer is the second leading cause of death worldwide, an average of one in six deaths is 
due to cancer [1]. Considerable research efforts have been devoted to cancer diagnosis and 
treatment techniques to lessen its impact on human health. Cancer prediction’s major focus 
is on cancer susceptibility, recurrence, and prognosis, while the aim of cancer detection is 
the classification of tumor types and identification of markers for each cancer such that we 
can build a learning machine to identify specific metastatic tumor type or detect cancer at 
their earlier stage. With the increased awareness of precision medicine and early detection 
techniques matured over years of technology development [2-4], including particularly 
many detection screens achieving a sensitivity around 70-80% [5], the demand for applying 
novel machine learning methods to discover new biomarkers has become one of the key 
driving factors in many clinical and translational applications.  
Deep learning (DL), a branch of Artificial Intelligence, is a family of multi-layer neural 
network models that excel at the problem of learning from big data [6]. Similar to other 
machine learning methods, DL consists of the training step where the estimation of network 
parameters from a given training dataset is carried out, and the testing step that utilizes the 
trained network to predict outputs of new input data. The accumulation of whole 
transcriptomic profiling of tumor samples enabled the pursuit of DL model for better 
accuracy and innovative interpretability for cancer type prediction. One prominent resource 
of cancer transcriptomic profiling is The Cancer Genome Atlas (TCGA) which consists of 
more than 11,000 tumors from 33 most frequent cancer types[7]. Several DL models have 
been developed for early cancer diagnosis. Ahn, et al., [8] designed a fully connected deep 
neural network (DNN) trained using a dataset of 6,703 tumor and 6,402 normal samples, 
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and provided an initial assessment of individual gene’s contribution to the final 
classification. Lyu, et al., [9] and Li et al. [10] extended such effort to classifying  
individual tumor types. Li et al. proposed a k-nearest neighbors (KNN) algorithm coupled 
with a genetic algorithm for gene selection and achieved >90% accuracy for predicting 31 
cancer types. Lyu et al. proposed a CNN model with 2D mapping of the gene expression 
samples as input matrices and achieved >95% accuracy for all 33 TCGA cancer types.  Lyu 
et al., also provided a data interpretation approach based on Guided Grad-Cam [11]. 
GeneCT [12] is another attempt which constrains the input genes to 2 categories: 
oncogenes and tumor suppressors (1,076 genes in total) to determine the cancerous status 
that includes transcription factors (1,546 genes) to classify samples to the tissue of origin. 
The paper reported an overall accuracy of 97.8% with the 10-fold cross-validation. Instead 
of using transcriptomic data, DeepCNA [13], a CNN based classifier, utilized ~15,000 
samples with copy number aberrations (CNAs) from COMICS [14] and the HiC data from 
2 human cell-lines and achieved an accuracy ~60% to discern 25 cancer types. While all 
these attempts achieved high accuracy to some extent, these methods ignore the existence 
of tissue of origin within each cancer type. Without removing the influence of normal 
tissues during cancer classification, the implementation of data interpretation scheme will 
unlikely to differentiate tissue-specific genes or cancer-type-specific genes. Thus, it is 
impossible to perform functional analysis or select biomarkers for cancer detection from 
such models. Morever, none of these studies systematically evaluated different CNN model 
constructions and their impact on the classification accuracy.  
In one of our earlier attempts [15], Chen, et al, constructed an autoencoder system 
(GSAE) with embedded pathways and functional gene-sets at each input node to reduce 
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the number of weights to be estimated. They applied the GSAE to classify breast cancer 
subtypes. Here we presented a study of different CNN models constructed for different 
input data formats. These models systematically interrogate the capacity of the convolution 
kernels. Utilizing the entire collection of TCGA gene expression data sets, covering all 33 
cancer types and nearly 700 normal samples from various tissues of origin, we examined 
the accuracies of tumor type prediction before and after removing the influence of tissue-
specific genes’ expression. In addition, we proposed a unique model interpretation scheme 
to examine the impact of all key genes participated in the DL prediction machinery and 
demonstrated the unique characteristics of the proposed CNN models and the feasibility of 
extracting diagnostic markers for future validation studies.   
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Methods 
Datasets 
We downloaded pan-cancer RNA-Seq data from The Cancer Genome Atlas (TCGA) [16] 
by an R/Bioconductor package TCGAbiolinks [17] in December 2018. The dataset 
contained 10340 and 731 samples for 33 cancer types and 23 normal tissues, respectively. 
We represented gene expression by 𝑙𝑜𝑔2(𝐹𝑃𝐾𝑀 + 1), where FPKM is the number of 
fragments per kilobase per million mapped reads. Genes with low information burden 
(mean < 0.5 or st. dev. < 0.8) across all TCGA samples, regardless their cancer types, were 
removed. We specifically chose a collection of relative higher overall expression and high 
variable genes in order to reduce the number of non-informative, or noise-sensitive features, 
within the dataset.  Total of 7,091 genes remained after the filtering step. In order to round 
inputs dimension and facilitate modeling part, nine zeros were added to the gene 
expressions for having vectors with the length of 7,100. We also collected the PAM50 
subtypes of 864 breast cancer (BRCA) samples from TCGA [16]. To test the robustness of 
our models, we added Gaussian noises with zero mean and standard deviations of 0-500% 
(k) of ith gene average (i), or 𝑁(0, 𝑘𝜇) to each gene. We set noisy gene expression level 
to 0 if noise added expression level is less than 0. 
 
Proposed models 
Different CNN models were proposed for cancer type prediction. Each model aims to 
address a specific aspect of modeling the gene expression data.  Few methods were 
proposed earlier to address input gene order and optimizing the arrangement of genes that 
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leads to best prediction results in [9] where genes were ordered by their chromosomal 
positions. In this paper, we kept genes in one preset order but instead, exploit the design of 
CNN kernels to learn correlations among genes. The other consideration is the depth of the 
CNN. Although deeper CNN models are known to produce more accurate classifications  
in computer vision [6], several studies have shown that increasing the depth of CNN 
models on biological data does not always lead to  improvement on performance [18]. Here 
we constrained our designs to include only one layer of convolution. In fact, shallower 
models are preferred for problems such as cancer type prediction, where there are limited 
samples relative to the number of parameters.  Such shallow models avoid overfitting and 
also demand fewer resources for training[19, 20]. Based on these two considerations, we 
discuss three different CNN designed next.  
 
CNN with vectorized input. This CNN model takes the gene expression as a vector and 
applies one-dimensional kernels to the input vector. The output of 1-D convolutional layer 
is then passed to a maxpooling layer, a Fully Connected (FC) layer, and a prediction layer 
(Figure 1A). For the sake of simplicity, we call this model 1D-CNN.  The main nuance 
between the proposed 1D-CNN and other counterpart CNNs for applications such as time 
series prediction is that the stride of the convolution is same as the length of kernel size. 
As a matter of fact, in some applications, 1D CNN is harnessed to capture temporal 
relationships between adjacent values in the input. However, in our case, since we are not 
confident that there are correlations among neighboring gene expression values in the input 
vector, we choose the stride of CNN as big as the kernel size to capture only the global 
features associated with this kernel. 
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CNN with matrix input. The second CNN model follows the most commonly practiced 
types of CNN applications in computer vision where the input has a 2-D format like an 
image. This CNN includes 2D kernels to extract local features in the input Figure 1B. 
Similar to [9], we reshaped the input gene expression into the 2D space without any specific 
arrangement to construct an image-like input before feeding it to the 2D CNN. The 2D 
CNN includes the convolutional layer with the 2D kernel, a maxpooling layer, an FC layer, 
and a prediction layer. For convenience, we term this model as the 2D-Vanilla-CNN. 
 
CNN with matrix input and 1D kernels. The third model is the 2D-Hybrid-CNN, which 
is inspired by the parallel towers in the Resnet modules [21] and simplicity of our proposed 
1D-CNN.  It is proposed to take advantage of having 2-D inputs with simple 1D 
convolution operations. In this model, as can be seen in Figure 1C, two 1D-kernels slide 
over the inputs, where one with the size of a row slides vertically and the other one with 
the size of a column slides horizontally across the 2D input. The outputs of two 1D-kernels 
are then passed through a maxpooling layer before being concatenated and fed into the FC 
and prediction layers. As in the Resnet modules, we believe this design can capture more 
global unstructured features in the input gene expression.  
 
Implementation of 2D-3Layer-CNN. In We implemented the model proposed in [9] with 
all details in Keras DL platform and named it 2D-3Layer-CNN in order to have a fair side-
by-side comparison between CNN models developed in this paper. This model contains 
three CNN modules which in each one Batch Normalization, Activation Function (AF), 
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and Maxpooling are used in a cascade manner. The output of last CNN module is fed into 
two FC layers and finally softmax layer is used for predicting 33 different cancer types.  
CNN Model Interpretation 
We utilized guided gradient saliency visualization method provided by the Keras 
visualization package keras-vis [22]. This method calculates the output gradient classes 
with respect to a small change in gene expressions. The positive values of these changes 
prime us the importance of those gene expressions in the inputs [23]. In the saliency map 
generation step, each sample was fed into the model to construct an interpretation map. We 
then summarized each cancer type as well as for the normal samples by averaging across 
all samples of the group and constructed a gene-effect matrix of 7,091x34 (33 cancer type 
and one normal class) that contains gene-effect scores with range of [0, 1] with 1s have 
maximum effect and 0 to no effect. A gene with a gene-effect score greater than 0.5 was 
defined as a marker gene for a cancer. 
 
Results  
Model construction, hyperparameter selection and training 
All of the three models were implemented by Keras [24] DL platform. All of the codes can 
be found at https://github.com/chenlabgccri/CancerTypePrediction. The input for 1D-CNN 
(Figure 1A) is a 1D vector following gene symbol’s alphabetic order, while inputs for 2D-
Vanilla-CNN and 2D-Hybrid-CNN (Figure 1B,C) models were reshaped to 100 rows by 
71 columns matrix. Four of the key hyperparameters known as the number and size of 
kernels, the stride of kernels, and the number of nodes in the FC layer were tuned by Grid 
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search method provided in [25]. The Tables 1A and B show all sets of parameters were 
chosen for 1D-CNN and 2D-Vanilla-CNN models respectively, and their statistical 
measures on train and test pools. In addition, Categorical Cross Entropy as the loss 
function, Categorical accuracy as training metric and the Adam optimizer were selected 
for all 3 CNN models. The epoch and batch size were chosen as 50 and 128, respectively, 
with the early stopping set with patience = 4 to stop the learning in the case that categorical 
accuracy did not improve in four consecutive epochs. Finally, ReLU was used as the AF 
and softmax as the prediction layer at the final layer for of all the models. 
All three CNN models were trained with all 10,340 tumor samples initially. To evaluate 
the training procedure and their robustness against overfitting, we examined loss functions 
for 3 models Figure 2A using 80%-20% splitting for training and validation, and we 
observed converges to ~0 loss after 10 epochs (where validation’s loss at about 0.10 with 
no obvious overfitting). The model in [9] was trained and tested with same procedure. As 
can be seen in the Figure 2A, the convergence of this model is slower than all proposed 
three models in this paper. 
In order to avoid the bias impacted by stochastic dependency nature of neural networks 
during training, the 5-fold cross validation was repeated six times (due to the time 
constraint) and their mean and standard deviation of the classification accuracy were 
reported for all models. Figure 2B (light blue bars) showed classification accuracy at 
95.5±0.1%, 94.87±0.04%, 95.7±0.1% for 1D-CNN, 2D-Vanilla-CNN and 2D-Hybrid-
CNN, respectively.  
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Assessing the impact of tissue-specific features on cancer type prediction 
Considering the tissues of origin when classify tumor samples, previous studies either 
omitting this important factor by only training the DL machine with tumor samples and 
then looking for cancer driver genes [9], or training two models: with only cancer 
associated genes (tumor DL model) or transcription factors (normal DL model) [10]. To 
observe the influence of tissues of origin with DL model trained with tumor sample only, 
we fed all 731 normal samples that matched to 23 TCGA cancer types into 1D-CNN model 
trained on 33 cancer types in the previous section. As is shown in Figure 2C, 19 of 23 
normal classes are classified into their corresponding cancer type, where normal samples 
from kidney (KICH, KIRC and KIRP), liver (CHOL and LIHC), lung (LUAD and LUSC) 
or digestive system (ESCA and STAD) are clearly grouped together, indicating a strong 
possibility that DL machine was partially trained to recognize tissues of origin. When we 
examined the classification results of tumor samples (Figure 2D), the major classification 
errors are also within kidney, lung (both boxed in Figure 2D), colon and rectum 
adenocarcinomas.   
Predicting cancer types without the influence of tissue of origin. 
In order to take into account the impact of tissue of origin in the model, we introduce a new 
label in the prediction layer where it takes all normal samples (regardless of their original 
tissue type designation). The 34th node in the prediction layer is responsible for removing 
the trace of tissue of origins from cancer samples, with the intention of achieving a robust 
cancer type prediction. All three models were re-trained with 33 nodes for tumor classes 
plus one node for normal samples (labeled as “Normal”) with the same architectures 
correspondingly. Similar to model training with 33 cancer-types only, we had a consistent 
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learning curve (Figure 3A) using 80%-20% splitting for training and validation, and 
converged to ~0 loss after 10 epochs without obvious overfitting. As shown in Figure 2B 
(brown bars), we achieved the overall accuracies 94.9±0.1%, 93.9±0.6%, 95.0±0.1% for 
1D-CNN, 2D-Vanilla-CNN and 2D-Hybrid-CNN, respectively, slightly lower than 33 
cancer only training, due to the introduction of normal samples (Precision at 92.5%, Figure 
3B).  
    Further evaluation of micro-averaged precision-recall statistics of 1D-CNN model with 
34 output nodes yielded some interesting observations (Figure 3B). The DL machine has 
a large discrepancy in precision-recall value of tumor type READ. This is due to the large 
number READ (rectum adenocarcinoma, 83) samples misclassified into COAD (colon 
adenocarcinoma), causing much lower recall level (48.8%) (Figure 3C), while 37 COAD 
samples are misclassified into READ types. Cholangiocarcinoma (CHOL) has only 36 
tumor samples total but a large fraction misclassified into hepatocellular carcinoma (LIHC, 
3 samples (~9%)) and Pancreatic Adenocarcinoma (PAAD, 2 samples). 
Cholangiocarcinoma is a bile duct cancer, and specifically the distal region (extrahepatic 
cholangiocarcinoma) is made up of the common bile duct that passes through the pancreas, 
thus potentially the cause of misclassification. We have attempted to train with a separated 
kidney normal tissue group with no clear improvement (data not show). Evidently, the 
limited normal samples per tumor group leaves a lot of room to improve.  
Interpretation of the 1D-CNN model to investigate cancer marker genes 
We systematically investigated the 1D-CNN model to understand how the model predicted 
cancer types with the aim to identify cancer marker genes. The interpretation was 
accomplished by generating the saliency map (see Methods Section) of 1D-CNN model. 
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Interpretation of the 1D-CNN model to investigate cancer marker genes. We 
systematically interpreted the 1D-CNN model to get insight on how the model predicts 
cancer types and finally identify cancer marker genes. We first examined the distribution 
of gene-effect scores of saliency maps for all caner types, and generally they followed the 
power law (Figure 4A). We set criteria on the gene-effect scores to identify marker genes 
(see Methods). t-SNE plots on expression data of selected marker genes confirmed that the 
identified markers preserved the differences among classes even when stringent thresholds 
were set (score > 0.5 to > 0.9 yielding 2,090 to 91 unique marker genes, respectively; 
(Figure 4B). To include more potential cancer markers into the investigation, we used the 
threshold of 0.5 for subsequent analyses. We obtained a total of 3,683 markers (2,090 
unique genes) for all the 34 classes with minimum of 4 markers to maximum of 346 
(Figure 4C), or average ~108 markers per cancer type. Diffuse large B-cell lymphoma 
(DLBC), breast invasive carcinoma (BRCA), and prostate adenocarcinoma (PRAD) were 
found with the most markers (346, 323, and 230, respectively). Interestingly, the cancers 
that our model tended to confuse, such as lung cancers (adenocarcinoma [LUAD] and 
squamous cell carcinoma [LUSC]) and rectum adenocarcinoma (READ), had a much 
smaller number of markers (4, 4, and 8, respectively). The finding suggested our model’s 
low confidence in classifying cancer types with few marker genes and the requirement of 
additional modes of genomics profiles (methylation, etc.) to further discriminate cancer 
types within the same tissue of origin.  
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Discrimination capability of marker genes. We investigated whether simple linear-like 
differential expression between classes underlying the capacity of these marker genes. The 
99 marker genes with a gene-effect score > 0.5 obtained from the normal class indeed had 
significantly larger differences in the expressional level between pan-cancers and normal 
samples than other genes (t-test P = 1.4×10-3; Figure 4D), though the differences were 
moderate in magnitude (mean, 0.55 vs. 0.43). Taking BRCA as a demonstrating example, 
323 BRCA markers had a larger differential expression between BRCA and other cancer 
samples than 6,768 non-marker genes (P = 3.6×10-8; Figure 4E). The phenomenon held 
for all markers of any cancer types (P = 1.6×10-47). Taken together, our model indeed 
identified genes with differential expression between classes.  
 
Marker genes in the breast cancer group. We further examined a well-studied cancer 
type, BRCA, as a demonstrating example to the marker genes identified by our model. 
BRCA had 323 marker genes (gene-effect score > 0.5). Well-known specific markers of 
BRCA, such as GATA3 [26] and ESR1 [27] were ranked at the 13th and 98th among all 
genes. Their classifying capability was predominately in BRCA (gene-effect scores, 0.89 
and 0.67; Figure 4F). Also, we identified other promising novel markers of BRCA, such 
as GPRIN1 (the top marker gene with a score of 0.97; Figure 4F), EFNB1 (2nd, score = 
0.94), and FABP4 (3rd, score = 0.92), that warrant further investigations. 
 
Biological functions of marker genes. To understand biological functions underlying 
cancer classification, we performed a functional annotation analysis on marker genes of 
each cancer type or normal. Each set of marker genes were systematically tested for 
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enrichment in a chemical and genetic perturbation signature (the CGP collection) curated 
by the Molecular Signature Database (MSigDB)[28, 29]. With a criterion on one-tailed 
Fisher’s exact test at P < 0.001, we identified a total of 32 associated functions among the 
34 classes (Figure 4G). Among the top function-class pairs we identified several known 
cancer functions. For instance, a signature identified from a soft tissue cancer, ‘NIELSEN 
SCHWANNOMA DN’[30], was significantly associated with markers of sarcoma (SARC) 
(top 2nd significant function-class pair; P = 3.3×10-5). Also, marker genes of prostate 
adenocarcinoma (PRAD) were associated with a signature of androgen response, 
‘NELSON RESPONSE TO ANDROGEN UP’ [31](P = 5.8×10-4). We also identified 
several novel marker functions of cancers, such as ‘BASSO CD40 SIGNALING UP’ in 
testicular germ cell tumor (TGCT) (1st; P = 2.0×10-5), and ‘'WAKABAYASHI 
ADIPOGENESIS PPARG BOUND 8D’ in bladder urothelial carcinoma (BLCA) (3rd, P = 
4.1×10-5). Overall, functional annotation analysis validated what we expect and potentially 
revealed several novel mechanisms through the CNN model interpretation. However, much 
of the functional interrogation remained to be further studied.  
 
Breast cancer subtype prediction 
While predicting cancers from different anatomic sites may be relative straightforward, 
predicting cancer subtypes, such as breast cancer, is an ongoing research topic. Breast 
cancer is divided into four subtypes known as luminal (A&B), HER2 positive and basal 
(often triple negative breast cancers (TNBC)) breast cancers[32]. In order to accomplish 
this, we further trained 1D-CNN model with all breast cancer samples from four different 
subtypes plus the normal breast cancer and set prediction layer with 5 nodes. To further 
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simplify the 1D-CNN, the fully connected layer with 128 nodes was removed. After 
training, we achieved an average precision of 88.3% (details see Table 2). Not that the 
misclassification is mainly between luminal A & B classes (two inherently similar tumor 
subtypes), and Her2 class’ low classification error is due to the lack of information since it 
is defined as the gain in DNA copy number (not necessarily reflected in gene expression) 
and/or over-expression of ERBB2 gene. 
 
Discussion 
There were several critical issues that this paper addressed to improve the accuracy of our 
prediction and interpretation. Specifically, three CNN architectures were proposed to 
investigate an appropriate architecture for unstructured gene expressions for predicting 
cancer types. As is shown in Figure 2B, 1D-CNN and 2D-Hybrid-CNN achieved 
comparable accuracy (95.7%), which improves the result (95.6%) slightly in [9]. Note that 
2D-Vanilla-CNN contains only one layer and 32 kernels, whereas the 2D-3Layer-CNN 
consists of multiple DL modules, a much more complex architecture. In addition to what 
we summerized in Table 3 where number of parameters for each model, loss function value 
after training and testing, and execution time examples, we note several underlying design 
facts behind each proposed model.  
• The 1D-CNN is significantly simpler than the other models proposed in the literature. 
It does not require inputs to be arranged in a particular order and it has only one 
convolutional layer.  This much-simplified design induces a significant reduction in the 
number of hyperparameters (from 26 millions to ~200 thousand) to be estimated during 
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training. This is highly desirable in the DL applications in genomic studies due to the 
difficulty and the high cost in collecting large genomic data.  
• The 2D-Vanilla-CNN has around one million hyperparameters which are significantly 
more than those of the 1D-CNN. The model became more difficult to converge when 
the stride of the kernel was selected to be 1x1. Also, by sliding two separate 
convolutions kernels over the two orthogonal dimensions, it improved the accuracy due 
to the ability to capture more global features.  
While 2D-Hybrid-CNN may provide a slight advantage in terms of the averaged 
classification accuracy (Figure 2B), it has two times more hyperparameters and thus a 
higher computation burden compared with the 1D-CNN model. Therefore, we focused on 
the 1D-CNN model in most of our subsequent analysis.  
    2D-Vanilla-CNN has similar accuracy comparing to 1D-CNN, but has almost 5x more 
hyperparameters to train. In order to investigate the robustness of proposed models in 
presence of noise, both CNN models were tested with data added with different level of 
noise as explained in Methods section. In Figure 5, the 5-fold accuracy of 1D-CNN and 
2D-Vanilla-CNN while tested on different ratios of noise are represented. As it is shown, 
the performance of both models is extremely robust until noise ratio reaches 75% and then 
it gradually drops. Although both models have almost equal performance results until 75% 
noise ratio, 1D-CNN outperforms 2D-Vanilla-CNN in noise ratios above 75%. Thus, we 
can conclude 1D-CNN has more stable performance encountering unwanted noise 
compared to other models. 
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    We chose to combine tumor samples plus normal samples together to train a DL model 
with 34 nodes in the prediction layer such that we can eliminate the influence of tissue 
origin in cancer type prediction. The model not only achieved a good precision in 
predicting normal tissues (92.5% precision) but made few mistakes in distinguishing 
cancer types within the same tissue origin; examples include  KICH, KIRC, and KIRP, all 
of them are kidney cancers, where only 2 normal samples are classified into cancer groups 
(out of 128 normal kidney samples, Figure 3C). We will continue our work to investigate 
this issue by introducing yet another rich source of transcriptomic data from GTEx 
collection[33]. Furthermore, as suggested by previous studies[13, 15, 34-37], we may 
incorporate additional genome-wide profiling information, such as DNA mutation, copy 
number variation, and DNA methylation as additional input matrices to enrich the 
complexity for model training, and thus to improve the classification accuracy.  
    Our unique interpretation of the CNN for genomic data has shown its utility when we 
examined the gene-effect scores. While some of these differences are modest in magnitude, 
our DL machine had no trouble to classify tumors into their correct subtypes, indicating a 
simple linear classifier (i.e., expression high vs. low) might not explain the complexity of 
our CNN. In this sense, our CNN model had the benefit of capturing high-order interactions 
among these genes to make accurate predictions. 
 
Conclusions  
Taken together, we have presented three unique CNN architectures that take high 
dimension gene expression inputs and perform cancer type prediction while considering 
their tissue of origin. Our model achieved an equivalent 95.7% prediction accuracy 
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comparing to earlier published studies, however with a drastically simplified CNN 
construction and with a significant reduction from tissue of origin. This allows us to 
perform a normal interpretation of our CNN model to elucidate cancer markers for each 
cancer type, with hope in future refinement that will lead to markers for earlier cancer 
detection.  
 
List of Abbreviations 
ACC, adrenocortical cancer; BLCA, bladder urothelial carcinoma; BRCA, breast invasive 
carcinoma; CESC, cervical and endocervical cancer; CHOL, cholangiocarcinoma; COAD, 
colon adenocarcinoma; CNN, convolutional neural network; DL, deep learning; DLBC, 
diffuse large B-cell lymphoma; ESCA, esophageal carcinoma; GBM, glioblastoma 
multiforme; HNSC, head and neck squamous cell carcinoma; KICH, kidney chromophobe; 
KIRC, kidney clear cell carcinoma; KIRP, kidney papillary cell carcinoma; LAML, acute 
myeloid leukemia; LGG, lower grade glioma; LIHC, liver hepatocellular carcinoma; 
LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma; MESO, 
mesothelioma; OV, ovarian serous cystadenocarcinoma; P, P-value; PAAD, Pancreatic 
Adenocarcinoma; PCPG, pheochromocytoma and paraganglioma; PRAD, prostate 
adenocarcinoma; READ, rectum adenocarcinoma; SARC, sarcoma; SKCM, skin 
cutaneous melanoma; STAD, stomach adenocarcinoma; TCGA, The Cancer Genome 
Atlas; TGCT, testicular germ cell tumor; THCA, thyroid carcinoma; THYM, thymoma; 
UCEC, uterine corpus endometrioid carcinoma; UCS, uterine carcinosarcoma; UVM, 
uveal melanoma;  
 - 21 - 
Declarations 
Ethics approval and consent to participate 
Not applicable. 
Consent for publication 
Not applicable. 
Availability of data and material 
The dataset supporting the conclusions of this article is included within the article. 
Competing interests 
The authors declare that they have no competing interests. 
Funding 
This research and this article's publication costs were supported partially by the NCI Cancer 
Center Shared Resources (NIH-NCI P30CA54174 to YC), NIH (CTSA 1UL1RR025767-
01 to YC, and R01GM113245 to YH), CPRIT (RP160732 to YC and MM), and San 
Antonio Life Science Institute (SALSI Innovation Challenge Award 2016 to YH and YC 
and SALSI Postdoctoral Research Fellowship to YCC). The funding sources had no role 
in the design of the study and collection, analysis, and interpretation of data and in writing 
the manuscript. 
 
 - 22 - 
Authors' contributions 
All of the authors conceived the study. MM and YCC designed the model and performed 
data analysis. All authors interpreted the data and wrote the manuscript. All of the authors 
have read and approved the final manuscript.  
 
Acknowledgements  
The authors greatly appreciate the intensive discussion and constructive suggestions with 
all members from Machine Learning Interesting Group organized by Drs. Huang and Chen.   
 - 23 - 
References 
1. Siegel RL, Miller KD, Jemal A: Cancer statistics, 2018. CA Cancer J Clin 2018, 
68(1):7-30. 
2. Cohen JD, Li L, Wang Y, Thoburn C, Afsari B, Danilova L, Douville C, Javed AA, 
Wong F, Mattox A et al: Detection and localization of surgically resectable 
cancers with a multi-analyte blood test. Science 2018, 359(6378):926-930. 
3. Haendel MA, Chute CG, Robinson PN: Classification, Ontology, and Precision 
Medicine. N Engl J Med 2018, 379(15):1452-1462. 
4. Phallen J, Sausen M, Adleff V, Leal A, Hruban C, White J, Anagnostou V, Fiksel 
J, Cristiano S, Papp E et al: Direct detection of early-stage cancers using 
circulating tumor DNA. Sci Transl Med 2017, 9(403):eaan2415. 
5. Schiffman JD, Fisher PG, Gibbs P: Early detection of cancer: past, present, and 
future. Am Soc Clin Oncol Educ Book 2015:57-65. 
6. LeCun Y, Bengio Y, Hinton G: Deep learning. Nature 2015, 521(7553):436-444. 
7. Grossman RL, Heath AP, Ferretti V, Varmus HE, Lowy DR, Kibbe WA, Staudt 
LM: Toward a Shared Vision for Cancer Genomic Data. N Engl J Med 2016, 
375(12):1109-1112. 
8. Ahn T, Goo T, Lee C-h, Kim S, Han K, Park S, Park T: Deep Learning-based 
Identification of Cancer or Normal Tissue using Gene Expression Data. In: 
2018 IEEE International Conference on Bioinformatics and Biomedicine (BIBM): 
2018: IEEE; 2018: 1748-1752. 
9. Lyu B, Haque A: Deep learning based tumor type classification using gene 
expression data. In: Proceedings of the 2018 ACM International Conference on 
Bioinformatics, Computational Biology, and Health Informatics: 2018: ACM; 
2018: 89-96. 
10. Li Y, Kang K, Krahn JM, Croutwater N, Lee K, Umbach DM, Li L: A 
comprehensive genomic pan-cancer classification using The Cancer Genome 
Atlas gene expression data. BMC Genomics 2017, 18(1):508. 
11. Selvaraju RR, Cogswell M, Das A, Vedantam R, Parikh D, Batra D: Grad-cam: 
Visual explanations from deep networks via gradient-based localization. In: 
Proceedings of the IEEE International Conference on Computer Vision: 2017; 
2017: 618-626. 
12. Sun K, Wang J, Wang H, Sun H: GeneCT: a generalizable cancerous status and 
tissue origin classifier for pan-cancer biopsies. Bioinformatics 2018, 
34(23):4129-4130. 
13. Yuan Y, Shi Y, Su X, Zou X, Luo Q, Feng DD, Cai W, Han ZG: Cancer type 
prediction based on copy number aberration and chromatin 3D structure with 
convolutional neural networks. BMC Genomics 2018, 19(Suppl 6):565. 
14. Forbes SA, Beare D, Gunasekaran P, Leung K, Bindal N, Boutselakis H, Ding M, 
Bamford S, Cole C, Ward S et al: COSMIC: exploring the world's knowledge of 
somatic mutations in human cancer. Nucleic Acids Res 2015, 43(Database 
issue):D805-811. 
15. Chen HH, Chiu YC, Zhang T, Zhang S, Huang Y, Chen Y: GSAE: an autoencoder 
with embedded gene-set nodes for genomics functional characterization. BMC 
Syst Biol 2018, 12(Suppl 8):142. 
 - 24 - 
16. Ciriello G, Gatza ML, Beck AH, Wilkerson MD, Rhie SK, Pastore A, Zhang H, 
McLellan M, Yau C, Kandoth C et al: Comprehensive Molecular Portraits of 
Invasive Lobular Breast Cancer. Cell 2015, 163(2):506-519. 
17. Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, Sabedot TS, 
Malta TM, Pagnotta SM, Castiglioni I et al: TCGAbiolinks: an R/Bioconductor 
package for integrative analysis of TCGA data. Nucleic Acids Res 2016, 
44(8):e71. 
18. Min S, Lee B, Yoon S: Deep learning in bioinformatics. Brief Bioinform 2017, 
18(5):851-869. 
19. Ioffe S, Szegedy C: Batch normalization: Accelerating deep network training 
by reducing internal covariate shift. arXiv preprint arXiv:150203167 2015. 
20. Srivastava N, Hinton G, Krizhevsky A, Sutskever I, Salakhutdinov R: Dropout: a 
simple way to prevent neural networks from overfitting. The Journal of 
Machine Learning Research 2014, 15(1):1929-1958. 
21. He K, Zhang X, Ren S, Sun J: Deep residual learning for image recognition. In: 
Proceedings of the IEEE conference on computer vision and pattern recognition: 
2016; 2016: 770-778. 
22. Kotikalapudi R: keras-vis. In.: GitHub; 2017. 
23. Simonyan K, Vedaldi A, Zisserman A: Deep inside convolutional networks: 
Visualising image classification models and saliency maps. arXiv preprint 
arXiv:13126034 2013. 
24. Chollet F: Keras. In.; 2015. 
25. Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, Blondel 
M, Prettenhofer P, Weiss R, Dubourg V: Scikit-learn: Machine learning in 
Python. Journal of machine learning research 2011, 12(Oct):2825-2830. 
26. Shaoxian T, Baohua Y, Xiaoli X, Yufan C, Xiaoyu T, Hongfen L, Rui B, Xiangjie 
S, Ruohong S, Wentao Y: Characterisation of GATA3 expression in invasive 
breast cancer: differences in histological subtypes and immunohistochemically 
defined molecular subtypes. J Clin Pathol 2017, 70(11):926-934. 
27. Duffy MJ: Predictive markers in breast and other cancers: a review. Clin Chem 
2005, 51(3):494-503. 
28. Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, Mesirov 
JP: Molecular signatures database (MSigDB) 3.0. Bioinformatics 2011, 
27(12):1739-1740. 
29. Liberzon A: A description of the molecular signatures database (MSigDB) web 
site. In: Stem Cell Transcriptional Networks. Springer; 2014: 153-160. 
30. Nielsen TO, West RB, Linn SC, Alter O, Knowling MA, O'Connell JX, Zhu S, Fero 
M, Sherlock G, Pollack JR et al: Molecular characterisation of soft tissue 
tumours: a gene expression study. Lancet 2002, 359(9314):1301-1307. 
31. Nelson PS, Clegg N, Arnold H, Ferguson C, Bonham M, White J, Hood L, Lin B: 
The program of androgen-responsive genes in neoplastic prostate epithelium. 
Proc Natl Acad Sci U S A 2002, 99(18):11890-11895. 
32. Guo Y, Shang X, Li Z: Identification of cancer subtypes by integrating multiple 
types of transcriptomics data with deep learning in breast cancer. 
Neurocomputing 2019, 324:20-30. 
 - 25 - 
33. Consortium G: Genetic effects on gene expression across human tissues. Nature 
2017, 550(7675):204. 
34. Chatterjee S, Iyer A, Avva S, Kollara A, Sankarasubbu M: Convolutional Neural 
Networks In Classifying Cancer Through DNA Methylation. arXiv preprint 
arXiv:180709617 2018. 
35. Si Z, Yu H, Ma Z: Learning deep features for dna methylation data analysis. 
IEEE Access 2016, 4:2732-2737. 
36. Chiu YC, Chen HH, Zhang T, Zhang S, Gorthi A, Wang LJ, Huang Y, Chen Y: 
Predicting drug response of tumors from integrated genomic profiles by deep 
neural networks. BMC Med Genomics 2019, 12(Suppl 1):18. 
37. Luo P, Ding Y, Lei X, Wu FX: deepDriver: Predicting Cancer Driver Genes 
Based on Somatic Mutations Using Deep Convolutional Neural Networks. 
Front Genet 2019, 10:13. 
  
 - 26 - 
Tables 
Table 1A. Different hyperparameter settings for 1D-CNN model based on the trained and 
tested statistical measures. The final selected parameters are highlighted. 
Hyperparameters  Loss 
dense layer 
size 
 
filter 
 
kernel 
 mean 
train_score 
stdev 
train_score 
mean 
test_score 
stdev 
test_score 
64 (1, 50) 8  0.069 0.031 0.167 0.023 
64 (1, 50) 16  0.037 0.013 0.140 0.007 
64 (1, 50) 32  0.023 0.003 0.132 0.006 
64 (1, 50) 64  0.013 0.002 0.128 0.006 
128 (1, 50) 8  0.032 0.008 0.147 0.006 
128 (1, 50) 16  0.027 0.014 0.138 0.014 
128 (1, 50) 32  0.011 0.003 0.121 0.009 
128 (1, 50) 64  0.004 0.001 0.126 0.012 
512 (1, 50) 8  0.009 0.000 0.138 0.008 
512 (1, 50) 16  0.006 0.001 0.127 0.003 
512 (1, 50) 32  0.124 0.179 0.265 0.160 
512 (1, 50) 64  0.003 0.002 0.125 0.008 
64 (1, 71) 8  0.072 0.009 0.177 0.009 
64 (1, 71) 16  0.044 0.009 0.149 0.006 
64 (1, 71) 32  0.036 0.011 0.135 0.009 
64 (1, 71) 64  0.016 0.004 0.124 0.012 
128 (1, 71) 8  0.046 0.007 0.154 0.015 
128 (1, 71) 16  0.027 0.006 0.135 0.015 
128 (1, 71) 32  0.014 0.002 0.129 0.016 
128 (1, 71) 64  0.008 0.001 0.119 0.003 
512 (1, 71) 8  0.023 0.018 0.152 0.023 
512 (1, 71) 16  0.009 0.008 0.132 0.017 
512 (1, 71) 32  0.004 0.002 0.123 0.008 
512 (1, 71) 64  0.011 0.016 0.134 0.015 
64 (1, 100) 8  0.088 0.010 0.172 0.015 
64 (1, 100) 16  0.066 0.014 0.162 0.009 
64 (1, 100) 32  0.037 0.007 0.132 0.009 
64 (1, 100) 64  0.024 0.009 0.128 0.013 
128 (1, 100) 8  0.058 0.001 0.164 0.009 
128 (1, 100) 16  0.031 0.008 0.144 0.014 
128 (1, 100) 32  0.019 0.004 0.128 0.008 
128 (1, 100) 64  0.016 0.010 0.137 0.027 
512 (1, 100) 8  0.031 0.013 0.155 0.014 
512 (1, 100) 16  0.009 0.001 0.135 0.009 
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Table 1B. Different hyperparameter settings for 2D-Vanilla-CNN model based on the 
trained and tested statistical measures. The final selected parameters are highlighted. 
Hyperparameters  Loss 
dense layer 
size 
 
filter 
 
kernel 
 
stride 
 mean  
train_score 
stdev  
train_score 
mean  
test_score 
stdev  
test_score 
128 32 (7, 7) (1, 1)  20.999 18.228 21.281 14.904 
128 32 (7, 7) (2, 2)  0.005 0.002 0.192 0.022 
128 32 (10, 10) (1, 1)  21.398 18.582 21.771 15.298 
128 32 (10, 10) (2, 2)  0.009 0.003 0.187 0.008 
128 32 (20, 20) (1, 1)  0.027 0.004 0.202 0.029 
128 32 (20, 20) (2, 2)  0.043 0.011 0.206 0.009 
128 64 (7, 7) (1, 1)  10.213 17.688 10.566 14.618 
128 64 (7, 7) (2, 2)  0.004 0.001 0.187 0.018 
128 64 (10, 10) (1, 1)  31.430 1.149 31.675 1.019 
128 64 (10, 10) (2, 2)  0.012 0.006 0.177 0.014 
128 64 (20, 20) (1, 1)  12.020 18.052 12.149 14.818 
128 64 (20, 20) (2, 2)  0.055 0.016 0.204 0.020 
512 32 (7, 7) (1, 1)  21.245 18.419 21.175 14.815 
512 32 (7, 7) (2, 2)  10.944 18.953 11.022 15.306 
512 32 (10, 10) (1, 1)  10.964 18.987 11.148 15.482 
512 32 (10, 10) (2, 2)  0.003 0.001 0.213 0.025 
512 32 (20, 20) (1, 1)  10.988 19.002 11.132 15.436 
512 32 (20, 20) (2, 2)  1.110 1.849 1.271 1.397 
512 64 (7, 7) (1, 1)  31.430 1.149 31.675 1.019 
512 64 (7, 7) (2, 2)  10.213 17.688 10.560 14.622 
512 64 (10, 10) (1, 1)  31.497 1.211 31.648 1.087 
512 64 (10, 10) (2, 2)  20.628 17.858 20.481 14.363 
512 64 (20, 20) (1, 1)  11.299 16.825 11.562 13.969 
512 64 (20, 20) (2, 2)  12.020 18.046 12.152 14.776 
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Table 2. Breast cancer subtype classification using 1D-CNN model 
Class name Precision Recall F1-score Support 
Basal 0.973 0.980 0.976 147 
Her2 0.829 0.853 0.841 68 
Luminal A 0.894 0.927 0.910 437 
Luminal B 0.810 0.780 0.795 186 
Normal 0.857 0.462 0.600 26 
Avg/Total 0.883 0.884 0.882 864 
 
Table 3. Hyperparameters and training times of 4 CNN models 
  Training  Testing  
DL model1 
Number of 
parameters Loss Accuracy  Loss Accuracy2 
Time3  
(seconds) 
1D-CNN 211,489 0.01 0.9971  0.1769 0.9567 80.3 
2D-Vanilla-CNN 1,420,737 0.007 0.9981  0.1778 0.9557 94 
2D-Hybrid-CNN 362,177 0.0149 0.996  0.1586 0.9582 80.8 
2D-3Layer-CNN 26,211,233 0.5149 0.9654  0.6875 0.9184 214.6 
2D-3Layer-CNN 
(with patience = 10) 
 0.1976 0.9869  0.3914 0.9419 379.17 
1. Early stopping is used for all models (all with patience = 4, except for the last model.) 
2. This is the result of 5-cv 
3. All DL model training were performed in a Linux server with Xeon 8176 CPU @2.1GHz, with 4x28 cores. 
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Figures 
 
Figure 1  - Illustration of three CNN models 
(A) 1D-CNN with input as a vector format with 7100 genes. (B) 2D-Vanilla-CNN, with an 
input reformatted as a 100x71 matrix, and one convolution layer. (C) 2D-Hybrid-CNN, 
similar input as in (B) but with two parallel convolution layers, vertical and horizontal, as 
in (A). (D) The performance of 1D-CNN and 2D-Vanilla-CNN when they are tested on 
different noise ratios added to the inputs. 
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Figure 2  - Cancer type prediction performance of three CNN models trained with 
tumor samples only. 
(A) Learning curves for all three CNN models. (B) Micro-averaged accuracy of three CNN 
models when trained with only tumor samples (light blue) from 33 tumor types, and with 
tumors and normal samples together (light brown). (C) Confusion matrix of normal 
samples prediction from 1D-CNN model trained with 33 tumor types only.  
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Figure 3  - Cancer type prediction performance of three CNN models trained with 
combined tumor and normal samples. 
(A) Learning curves for all three CNN models trained with combined tumor and normal 
samples. (B) Precision (light blue) and recall (light brown) of 1D-CNN model when trained 
with combined tumor normal samples. (C) Confusion matrix of all sample prediction from 
1D-CNN model trained with 33 tumor types + normal.  
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Figure 4  - Interpretation of the 1D-CNN model 
(A) Distributions of gene-effect scores for individual cancer and normal classes. (B) t-SNE 
plots of pan-cancer and normal samples by expression of marker genes identified using 
different thresholds. (C) Marker genes identified in each class with a criterion of gene-
effect score > 0.5. (D-E) Differential expression of marker genes and other genes between 
sample classes. Here differential expression is presented by an absolute difference between 
a class (normal or BRCA) and all other samples in log2(FPKM+1). (F) Pan-classes gene-
effect scores of three marker genes of BRCA. (G) Functions associated with marker genes 
identified in each class. 
 
Figure 5  - CNN models testing on noisy data.  
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Classification accuracy on TCGA data with different additive Gaussian noise added. Both 
classifiers were trained with original TCGA data, but tested on TCGA data + Gaussian 
noise.   
 
